Work

Genome-wide Analysis of Androgen Receptor Function in Prostate Cancer

Year: 2012
Type: dissertation
Abstract: The androgen receptor (AR) mediates the effects of the two physiological male sex hormones (androgens) testosterone and 5α-dihydrotestosterone (DHT) that are critical in the development and maintenance of the male sexual characteristics. Androgens and AR signaling play an important role in the growth of prostate gland and in the development and progression of prostate cancer (PCa). AR is a member of the steroid receptor family and is a ligand-inducible transcription factor. Upon binding to male sex steroids, AR acquires a new conformational state, translocates to the nucleus, homodimerizes and binds to regulatory regions called androgen-response elements on target cell chromatin, as well as interacts with coregulatory proteins, sequence-specific transcription factors, and the basal transcription machinery to regulate gene expression (transcription). AR regulates distinct transcriptional programs in androgen-dependent and castration-resistant (androgen-independent) prostate cancer (CRPC). Gene transcription is a well-orchestrated process of multiple events involving chromatin modifiers, coregulators and collaborating transcription factors, occurring in an ordered and sequential fashion. This strictly regulated process is tightly controlled at every stage to govern cell growth and homeostasis. Details of the ways by which AR regulates gene expression in a genome-wide fashion are still not clear. This warrants an in-depth study of the molecular basis of genome-wide AR function in response to cognate ligands under androgen-dependent and CRPC conditions, their recruitment to specific genomic sites and the role of other transcription factors, chromatin modifiers and coregulators in modulating AR function. This study aimed at investigating genome-wide AR binding sites in prostate cancer cells by using ChIP-sequencing technique to understand the androgen-regulated gene expression. Genome-wide AR binding sites (ARBs) in the presence of physiological androgens and partial agonist/antagonists were profiled and respective downstream target genes were characterized. Particular emphasis was paid to investigate the role of the collaborating transcription factor FoxA1 in mediating recruitment of AR to the chromatin and in androgen signaling, and prognostic value of FoxA1 expression in PCa. Furthermore, we explored the role of FoxA1 in defining cell type-specific recruitment of AR in two different PCa cell lines, and its influence on defining site-specific occupancy of two steroid receptors, namely AR and glucocorticoid receptor (GR), in PCa cells. Finally, the consequences of AR overexpression and its repercussions on genomic recruitment of AR to chromatin were investigated. Our work showed that nuclear receptors, such as AR and GR, employ distal modes of transcriptional regulation, as majority of the binding sites are located far from the transcription start sites. The physiological androgen DHT was more potent in recruitment of AR to the chromatin and mediating subsequent gene expression than partial androgen agonist/antagonists. This demonstrates that agonist-bound AR forms a more favorable conformation compared to partial agonist/antagonists-bound AR, and the resulting binding profiles as well as the transcription programs exhibit quantitative differences. The genome-wide DHT-bound ARBs were significantly over-represented for FoxA1 cis-element, suggesting a global role of FoxA1 in AR function. The identification of genome-wide FoxA1 binding sites correlating with AR binding sites led to a paradigm shift in understanding the role of FoxA1 in androgen signaling. FoxA1 has previously been considered as a pioneering factor with the ability to bind compact chromatin and prime it for nuclear receptor binding. Our findings reveal that FoxA1 has a dual role in regulating AR functions and we defined three distinct classes of ARBs in PCa cells that were commensurate with the androgen-regulated transcription programs. Importantly, FoxA1 levels significantly correlate with prostate cancer-specific disease survival as low FoxA1 levels predict good clinical outcome in primary PCa patients. Further analysis of the ARBs in two different PCa cell lines revealed that FoxA1 defines unique receptor binding sites in each cell line. Moreover, AR and GR binding specificity to chromatin was determined by FoxA1, when analyzed in a single PCa cell line in response to their respective ligands. Furthermore, the results also highlight the role of glucocorticoid as an anti-androgen, which attenuates AR-dependent transcription programs. In AR overexpressing PCa cells, we demonstrated sensitization to low levels of androgens due to enhancement in receptor binding. The association between AR levels and chromatin occupancy was also validated in two PCa xenografts, one with high and another with low AR expression levels.
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W1532142819
Cites: 274
Cited by: 1
Related to: 9